Error: Could not add to watchlist. X
+ Watchlist

Immuron Ltd

IMROY:US
Ticker Change
IMROY:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
16.34
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
16.34
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.06%
% Price Change
+0.10%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Immuron Limited operates as a biopharmaceutical company. The Company focuses on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron's technology platform is developing and producing an orally stable therapeutic for various immune mediated and inflammatory disorders.
Address
1233 High Street
Suite 1
Armadale, VIC 3143
Australia
Phone
61-3-9824-5254
Show More